Manufacturer
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Contents
Dimenhydrinate
Indication
Treatment and prophylaxis of motion sickness, Nausea and vertigo caused by Meniere's disease
Instruction
2-5 yr 12.5-25 mg 6-8 hrly. Max: 75 mg daily; 6-12 yr 25-50 mg 6-8 hrly. Max: 150 mg daily; ≥12 yr Same as adult dose. For prevention of motion sickness, 1st dose to be given at least 30 min before travelling.
Drug interaction
Increased sedation when used w/ other CNS depressants. May mask the early symptoms of ototoxicity when used w/ aminoglycosides or other ototoxic drugs. May potentiate the effects of other drugs w/ anticholinergic activity (e.g. TCAs).
Malaysia
